Drug General Information
Drug ID
Drug Name
Anti-EGFRvIII CAR T cells
Drug Type
CAR T Cell Therapy
Indication Glioblastoma multiforme [ICD-11: 2A00.0; ICD-9: 191] Phase 1 [1]
Beijing Sanbo Brain Hospital
Target and Pathway
Target(s) Epidermal growth factor receptor variant III (EGFR vIII) Target Info CAR-T-Cell-Therapy [1]
REF 1 ClinicalTrials.gov (NCT02844062) Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.